Diabetes Obes Metab 22(8):12631277 Davies M, Faerch L, Jeppesen OK, Pakseresht A, Pedersen SD, Perreault L et al (2021) Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial
This duality complicates its pharmacological targeting
Fiber is crucial for gut health, as TODAY.com explained previously
Many patients discover their non-response reflects a dosing schedule mismatch or concurrent medication interference rather than true pharmacological non-response, allowing successful treatment after targeted adjustments
Although there is a lack of robust specific evidence regarding the benefits of the influenza vaccine for patients with bronchiectasis, indirect evidence suggests that annual influenza vaccination can reduce mortality and morbidity and reduce healthcare costs in high-risk groups ( 3.1.6 Bacterial lysate The bacterial lysate OM-85 BV is an immunomodulator widely utilized to prevent acute attacks or exacerbations of COPD, chronic bronchitis, respiratory infections, chronic sinusitis, and other related conditions (56)
However, it can slow blood clotting and may interact with nitroglycerin or blood-pressure medications (NIH)
